| Johnson & Johnson’s vaccine protects against COVID-19 but not as strong as others already available, data released Friday from the company shows. Trials in the U.S. and seven other countries showed 66% effectiveness in its vaccine in preventing moderate to severe illness, the company said. It was 85% protective against the most serious symptoms. |  |
News Alert Friday, January 29 |
|
| | | | | | | | |
|
